FUMAGALLI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 3.164
AS - Asia 1.698
NA - Nord America 1.473
SA - Sud America 333
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 32
OC - Oceania 3
Totale 6.780
Nazione #
RU - Federazione Russa 2.466
US - Stati Uniti d'America 1.401
SG - Singapore 477
CN - Cina 464
IT - Italia 449
BR - Brasile 257
HK - Hong Kong 219
VN - Vietnam 168
KR - Corea 114
IN - India 94
DE - Germania 86
BD - Bangladesh 63
AR - Argentina 36
JP - Giappone 31
CA - Canada 30
FR - Francia 24
FI - Finlandia 23
GB - Regno Unito 23
MX - Messico 21
NL - Olanda 20
EC - Ecuador 17
IQ - Iraq 14
AT - Austria 12
ZA - Sudafrica 11
IE - Irlanda 10
PL - Polonia 10
ID - Indonesia 9
UA - Ucraina 9
ES - Italia 8
CL - Cile 6
CR - Costa Rica 6
MA - Marocco 6
UZ - Uzbekistan 6
KE - Kenya 5
SA - Arabia Saudita 5
BH - Bahrain 4
IL - Israele 4
PY - Paraguay 4
VE - Venezuela 4
AL - Albania 3
EG - Egitto 3
GT - Guatemala 3
MY - Malesia 3
PH - Filippine 3
PK - Pakistan 3
PT - Portogallo 3
SE - Svezia 3
TN - Tunisia 3
TR - Turchia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CH - Svizzera 2
CO - Colombia 2
CZ - Repubblica Ceca 2
EE - Estonia 2
HN - Honduras 2
JM - Giamaica 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 6.703
Città #
Moscow 858
Santa Clara 252
Hong Kong 215
San Jose 210
Ashburn 193
Singapore 183
Hefei 155
Council Bluffs 147
Seoul 112
Naples 84
Milan 82
Ho Chi Minh City 66
Bengaluru 62
Hanoi 43
Dallas 40
Munich 40
Beijing 39
Los Angeles 32
Rome 28
The Dalles 23
São Paulo 22
Miano 18
Kochi 16
New York 16
Nuremberg 16
Phoenix 14
Rio de Janeiro 13
Amsterdam 12
Helsinki 11
Brooklyn 10
Dublin 10
Atlanta 9
Brasília 9
Falkenstein 9
Mexico City 9
Montreal 9
Toronto 9
Vitulazio 9
Florence 8
Memphis 8
Turku 8
Baghdad 7
Boardman 7
Buffalo 7
Caserta 7
Chennai 7
Haiphong 7
North Bergen 7
Warsaw 7
Angri 6
Belo Horizonte 6
Chicago 6
Curitiba 6
Da Nang 6
Figino 6
Orem 6
Quito 6
San Francisco 6
San José 6
Tashkent 6
Vicenza 6
Bari 5
Formosa 5
Hải Dương 5
Johannesburg 5
Nairobi 5
Ribeirão Preto 5
Turin 5
Vienna 5
Bologna 4
Brescia 4
Denver 4
Guarulhos 4
London 4
Manama 4
Poços de Caldas 4
Queens 4
Tokyo 4
Trentola-Ducenta 4
Verona 4
Washington 4
Asunción 3
Baltimore 3
Boston 3
Bắc Ninh 3
Campinas 3
Campo Grande 3
Changsha 3
Concepción 3
Feira de Santana 3
Fortaleza 3
Frankfurt am Main 3
Gravataí 3
Guangzhou 3
Guatemala City 3
Guayaquil 3
Kingston 3
Lappeenranta 3
Newark 3
Padua 3
Totale 3.382
Nome #
Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy 207
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 161
Association of Obesity with Adverse Long-Term Outcomes in Hypertrophic Cardiomyopathy 153
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 150
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 146
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 145
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 137
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes 133
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis 127
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 120
Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis 117
Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study 117
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study 114
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study 112
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 112
Development of an Italian version of the Leicester cough questionnaire and its relationship with other symptom-specific measures for patients with chronic cough 111
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 110
Anticoagulation in atrial fibrillation. A large real-world update 109
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 109
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 107
Post-procedural fever after transcatheter aortic valve implantation: a retrospective single-centre study 102
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 102
From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy 99
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis 99
Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry 99
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy 95
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 94
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 92
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 92
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson–Fabry disease 90
Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor 90
PCSK9 Inhibitors “Fast Track” Use Versus “Stepwise” Lipid-Lowering Therapy in Patients with Acute Coronary Syndrome: A Retrospective Single-Center Study in a “Real-World” Population 89
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): A pilot study 89
Prognostic impact of right ventricular dysfunction in patients with severe aortic stenosis treated with trans-catheter aortic valve implantation 88
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 88
Change in prevalence of ATTR variants in Italy: results from a national survey 88
Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus 88
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 86
Somatically evoked cough responses help to identify patients with difficult-to-treat chronic cough: a six-month observational cohort study 85
International patient preferences for physician attire: results from cross-sectional studies in four countries across three continents 85
Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis 84
Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: An unresolved problem 84
Layman electrocardiographic screening using smartphone-based multiple‑lead ECG device in school children 84
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 84
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 83
β-blockers: Their new life from hypertension to cancer and migraine 83
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 81
Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis 81
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 80
Validation of a multiple‑lead smartphone-based electrocardiograph with automated lead placement for layman use in patients with hypertrophic cardiomyopathy 80
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 78
Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes? 78
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 78
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 77
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis 76
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis 76
MitraClip implantation in real-world: clinical relevance of different patterns of left ventricular remodeling 72
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry 72
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 71
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 71
Post-procedural fever after Transcatheter Aortic Valve Implantation (TAVI). A multi-centric study 70
Wild-type transthyretin cardiac amyloidosis: the need for a comprehensive geriatric assessment beyond age 70
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 64
Overweight and aging increase the risk of atrial fibrillation after cardiac surgery independently of left atrial size and left ventricular ejection fraction 63
Development of a smartphone-based app to support the differential diagnosis in patients with primary left ventricular hypertrophy 62
Use of Smartphone-operated ECG for home ECG surveillance in COVID-19 patients 61
Response to correspondence on 'Change in prevalence of ATTR variants in Italy' 59
Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study 58
Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drug 50
Effects of Vericiguat on the Mitochondrial Function and Clinical Outcomes in CRT Nonresponders Patients 46
Phenotypes of Vulnerability and Prognosis in Older Adults with Cardiovascular Disease 40
Impatto prognostico delle sindromi geriatriche nella gestione dell’amiloidosi cardiaca da transtiretina 38
Environmental Pollutant-Induced Cardiopathogenesis Through Immune Dysfunction: The Emerging Role of Micro- and Nanoplastics 37
A Geriatric Assessment Score Predicting 1-Year Mortality and Functional Decline After TAVR: The GASS-TAVR Study 29
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact 23
Totale 6.780
Categoria #
all - tutte 20.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20236 0 0 0 0 2 0 0 0 3 0 1 0
2023/2024137 0 0 4 1 2 0 1 29 9 15 33 43
2024/2025947 5 42 13 61 155 116 188 47 75 79 69 97
2025/20264.681 176 427 329 194 379 2.288 238 114 173 170 96 97
2026/20271.009 80 245 308 376 0 0 0 0 0 0 0 0
Totale 6.780